BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17968743)

  • 1. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations.
    Hewitt NJ; Lecluyse EL; Ferguson SS
    Xenobiotica; 2007; 37(10-11):1196-224. PubMed ID: 17968743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes.
    You L
    Chem Biol Interact; 2004 Apr; 147(3):233-46. PubMed ID: 15135080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies.
    Amacher DE
    Toxicol Mech Methods; 2010 May; 20(4):159-66. PubMed ID: 20218941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
    Braeuning A; Sanna R; Huelsken J; Schwarz M
    Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
    Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective.
    Chu V; Einolf HJ; Evers R; Kumar G; Moore D; Ripp S; Silva J; Sinha V; Sinz M; Skerjanec A
    Drug Metab Dispos; 2009 Jul; 37(7):1339-54. PubMed ID: 19389860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ; Lake BG
    Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pivotal role of hepatocytes in drug discovery.
    Soars MG; McGinnity DF; Grime K; Riley RJ
    Chem Biol Interact; 2007 May; 168(1):2-15. PubMed ID: 17208208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors.
    Boobis AR; Sesardic D; Murray BP; Edwards RJ; Singleton AM; Rich KJ; Murray S; de la Torre R; Segura J; Pelkonen O
    Xenobiotica; 1990 Nov; 20(11):1139-61. PubMed ID: 2275211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications.
    Park BK; Kitteringham NR
    Xenobiotica; 1990 Nov; 20(11):1171-85. PubMed ID: 2275213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and animal hepatocytes in vitro with extrapolation in vivo.
    O'Brien PJ; Chan K; Silber PM
    Chem Biol Interact; 2004 Nov; 150(1):97-114. PubMed ID: 15522264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytochrome P450 enzymes: a view on human in vivo findings.
    Hukkanen J
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):569-85. PubMed ID: 23121279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and induction of human cytochrome P450 enzymes: current status.
    Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
    Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assays for induction of drug metabolism.
    Lake BG; Price RJ; Giddings AM; Walters DG
    Methods Mol Biol; 2009; 481():47-58. PubMed ID: 19096794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of cytochrome P450 and phase II enzymes by xenobiotics in precision-cut tissue slices.
    Ioannides C
    Xenobiotica; 2013 Jan; 43(1):15-28. PubMed ID: 22742738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated induction of drug transporters and phase I and II metabolism in human liver slices.
    Olinga P; Elferink MG; Draaisma AL; Merema MT; Castell JV; Pérez G; Groothuis GM
    Eur J Pharm Sci; 2008 Apr; 33(4-5):380-9. PubMed ID: 18328680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes.
    Blanchard N; Richert L; Notter B; Delobel F; David P; Coassolo P; Lavé T
    Eur J Pharm Sci; 2004 Oct; 23(2):189-99. PubMed ID: 15451007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.